"This article was first published in the Spring 2023 issue of Critical Connections.

Among the many challenges for healthcare organizations created by the COVID-19 pandemic was drug shortages. The anticipatory purchasing of drugs around the world due to the uncertainty of COVID-19 and skyrocketing hospitalizations drove drug demand to an unprecedented high. Meanwhile, availability was reduced because manufacturers shut down to prevent the spread of COVID-19 and other supply chain disruptions. Although the shortages were predominantly related to drugs directly impacting patients with COVID-19, other drug classes were affected as well.

Critical Connections, the critical care industry’s only newsmagazine, provides information on cutting-edge topics in critical care useful to the entire multiprofessional team."